ARDT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

ARDT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire January 12, 2026 SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ardent Health, […]

WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab(TM) Designed to Transform Bioprocessing and Manufacturing

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufacturing. By combining advanced real-time process monitoring with Raman-based Process Analytical Technology (PAT) and predictive in-silico modeling, PatroLab(TM) enables real-time and smarter analytics, proactive control,

MNP Consumer Debt Index: Canadians Brace for Challenging 2026

CALGARY, Alberta, Jan. 12, 2026 (GLOBE NEWSWIRE) — Canadians are heading into the new year bracing for mounting financial challenges, with a strong majority (71%) expecting the cost of living to worsen. According to the latest MNP Consumer Debt Index conducted quarterly by Ipsos, this pessimism extends well beyond prices, reflecting a broader sense that

PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION

On January 9, 2026, Pierre Fabre Pharmaceuticals, Inc. received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) stating that the Agency is unable to approve the tabelecleucel Biologics License Application (BLA) in its present form. We are surprised and deeply disappointed by the FDA’s decision, particularly given the urgent and

AvantorĀ® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February, 11, and will hold a conference call to discuss the results

PENGUIN AI LAUNCHES HCC CODING & RISK ADJUSTMENT SOLUTION AS SNOWFLAKE NATIVE APP ON SNOWFLAKE MARKETPLACE

Joint customers can improve coding accuracy, strengthen compliant submissions, and strengthen RAF integrity with Penguin Ai’s HCC Coding & Risk Adjustment Snowflake Native App Penguin Ai, a healthcare artificial intelligence company, announced today the launch of its Hierarchical Condition Category (HCC) Coding & Risk Adjustment solution on Snowflake Marketplace. The Penguin Ai HCC coding solution,

Rigel Provides Business Update and 2026 Outlook

— Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues of $4.4 million — In the dose escalation phase of the Phase 1b study of R289 in patients with lower-risk MDS, R289 continues to be generally well tolerated. RBC-TI was achieved by 33% (6/18)

Community Memorial Hospital Chooses Oracle Health to Enhance Patient Care and Power Operational Excellence

Will use Oracle Health Clinical AI Agent to help doctors spend more time with patients Plans to replace disparate legacy systems with Oracle Health Foundation EHR to drive efficiency, improve care coordination Community Memorial Hospital (CMH) will replace its legacy health record systems with Oracle Health solutions to support innovation, optimize growth, and increase operational

Kaffea-X Launches a Digital Marketplace for Specialty Green Coffee, Introducing Standardized Pricing and Escrow-Based Trade Security

Kaffea-X today announced the launch of its digital marketplace for specialty green coffee, designed to address long-standing challenges in global coffee trading related to price opacity, fragmented attributes description standards, and counterparty risk. The platform introduces a standardized product identification system, alongside escrow-backed transaction settlement, providing market participants with transparent price discovery and institutional-grade payment

VRNS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Varonis Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the “Class Period”), have until March 9, 2026 to seek appointment as lead plaintiff of the Varonis class action lawsuit. Captioned Molchanov v. Varonis Systems,

Scroll to Top